-
Functional Areas
- Principal Recipient Start-Up
-
Legal Framework
- Overview
- Project Document
-
The Grant Agreement
- UNDP-Global Fund Grant Regulations
- Grant Confirmation
- Grant Confirmation: Face Sheet
- Grant Confirmation: Conditions
- Grant Confirmation: Conditions Precedent (CP)
- Grant Confirmation: Special Conditions (SCs)
- Grant Confirmation: Schedule 1, Integrated Grant Description
- Grant Confirmation: Schedule 1, Performance Framework
- Grant Confirmation: Schedule 1, Summary Budget
- Implementation Letters and Performance Letters
- Agreements with Sub-recipients
- Agreements with Sub-sub-recipients
- Signing Legal Agreements and Requests for Disbursement
- Language of the Grant Agreement and other Legal Instruments
- Amending Legal Agreements
- Other Legal and Implementation Considerations
- Legal Framework for Other UNDP Support Roles
-
Health Product Management
- Overview - Health Product Management
- UNDP Quality Assurance Policy
- Product Selection
- Quantification and Forecasting
- Supply Planning of Health Products
-
Sourcing and regulatory aspects
- Global Health Procurement Center (GHPC)
- Development of List of Health Products
- Development of the Health Procurement Action Plan (HPAP)
- Health Procurement Architecture
- Local Procurement of health products
- Procurement of Pharmaceutical Products
- Procurement of non-pharmaceutical Health Products
- Other Elements of the UNDP Procurement Architecture
- Submission of GHPC CO Procurement Request Form
- Guidance on donations of health products
- International freight, transit requirements and use of INCOTERMS
- Inspection and Receipt
- Storage
- Inventory Management
- Distribution
- Quality monitoring of health products
- Waste management
- Rational use
- Pharmacovigilance
- Risk Management for PSM of health products
- Compliance with the Global Fund requirements
- UNDP Health PSM Roster
-
Financial Management
- Overview
- Grant-Making and Signing
- Grant Implementation
- Sub-recipient Management
- Grant Reporting
- Grant Closure
- CCM Funding
- Import duties and VAT / sales tax
-
Monitoring and Evaluation
- Overview
- Differentiation Approach
- Monitoring and Evaluation Components of Funding Request
- Monitoring and Evaluation Components of Grant Making
- M&E Components of Grant Implementation
- Sub-Recipient Management
- Grant Reporting
-
Capacity development and transition, strengthening systems for health
- Overview
- Interim Principal Recipient of Global Fund Grants
- A Strategic Approach to Capacity Development
- Resilience and Sustainability
- Legal and Policy Enabling Environment
- Functional Capacities
- Capacity Development and Transition
- Transition
- Capacity Development Objectives and Transition Milestones
- Capacity Development Results - Evidence From Country Experiences
- Capacity development and Transition Planning Process
- Capacity Development and Transition - Lessons Learned
-
Risk Management
- Overview
- Introduction to Risk Management
-
Risk Management in the Global Fund
- Global Fund Risk Management Framework
- Local Fund Agent
- Challenging Operating Environment (COE) Policy
- Additional Safeguard Policy
- Global Fund Risk Management Requirements for PRs
- Global Fund Risk Management Requirements During Funding Request
- Global Fund Review of Risk Management During Grant Implementation
- Risk management in UNDP
- Risk Management in UNDP-managed Global Fund projects
- UNDP Risk Management Process
- Risk management in crisis settings
- Audit and Investigations
- Human rights, key populations and gender
- Human resources
-
Grant closure
- Overview
- Terminology and Scenarios for Grant Closure Process
-
Steps of Grant Closure Process
- 1. Global Fund Notification Letter 'Guidance on Grant Closure'
- 2. Preparation and Submission of Grant Close-Out Plan and Budget
- 3. Global Fund Approval of Grant Close-Out Plan
- 4. Implementation of Close-Out Plan and Completion of Final Global Fund Requirements (Grant Closure Period)
- 5. Operational Closure of Project
- 6. Financial Closure of Project
- 7. Documentation of Grant Closure with Global Fund Grant Closure Letter
Ensuring Data Quality
Reliable data is essential for program planning, implementation and performance management. Ensuring data quality implies having a system in place - including tools, processes and human resources – to assess the accuracy, reliability, precision, completeness and timeliness of data and to take remedial actions. The monitoring data collected from each Sub-recipient (SR) is consolidated by the Principal Recipient (PR).
The PR will diagnose systematic or procedural weaknesses at the SR level that lead to inaccurate, incomplete or delayed reporting to the PR and to the Global Fund which puts funding at risk. Data verification is therefore critical during implementation. The PR should ensure sufficient investments in HMIS components for data quality and data assurance: Revision of paper/digital tools, printing, training, formative supervision.
The Global Fund also supports routine data quality checks and audits (RDQA), as well as periodic Data Quality Reviews (DQR) at health facility and community levels. The WHO DQR framework is recommended as a harmonized and holistic approach to assess the quality of data collected from health facilities. This approach allows to quantify problems of data completeness, timeliness and accuracy according to program areas, identify weaknesses in the data management system and monitor performance of data quality over time. A national DQR can be implemented in collaboration with partners. The GF Country Team might also coordinate with the LFA the implementation of targeted DQRs. A data quality improvement plan should be developed based on the results of the DQR to address weaknesses in data.
At the Global Fund OIG audit of in-country data and data systems conducted in 2023, the OIG notes that Global Fund has developed detailed guidance and tools on monitoring programmatic data availability and quality at the country level. While there are well-designed guidelines and tools for monitoring and assurance, the OIG noted implementation challenges: “Regarding implementer monitoring of data quality, most issues were identified at the health facility level, where processes and controls over in-country HMIS are not always formalized and followed, and there are significant M&E staff capacity gaps impacting the robustness of monitoring of data quality. Outside health facilities, there are issues with monitoring, oversight, and supervision visits by national and regional entities. These reviews are often delayed, not performed, or do not result in improved data accuracy” (Source: Global Fund audit of In-country data and data systems, OIG, April 2023).
Since 2023, the Global Fund has been working with technical partners to develop the M&E System and Data Quality strategy that will provide an update on the data quality assurance mechanism.
GFPHST-led Data Quality Reviews
At the end of 2023 the GFPHST M&E team introduced Data Quality Reviews of aggregated grant-level results based on the comparison of PR-reported against LFA-verified data. Discrepancies exceeding a 5% threshold are explored by the grant M&E Specialist and PMU M&E Specialist, to understand the reasons. Most differences in reporting are attributable to reporting delays, revision of population estimates or reporting errors. The process of engagement between GFPHST and PMU contributes to better understanding of reporting requirements and reduction of reporting errors in subsequent reports. The outputs of this exercise feed into GFPHST information sessions on improved reporting.
During the debriefing conducted by the LFA following their verification of reported results, the PR is encouraged to clarify / discuss with the LFA any of the discrepancies identified between the reported and LFA-verified results, unless the reasons are obvious (e.g. improved reporting completeness between the PR reporting and LFA verification).
Loading resources
